Back

For clinicians with patients requiring soft-tissue repair, Restrata is a non-biologic, electrospun fiber matrix engineered to be similar to human ECM that activates granulation tissue in refractory wounds while maintaining tensile strength with flexibility.

Restrata is a revolution in soft-tissue repair.

Restrata is an engineered, fully resorbable, electrospun fiber matrix whose architecture resembles human ECM and supports cell ingrowth, retention, and differentiation. Representing a new approach to the treatment of acute and chronic wounds, Restrata utilizes the advantages of synthetic construction to launch a new era in healing.

Composed of non-woven, resorbable fibers, Restrata’s unique properties enable it to resist enzymatic degradation and persist in the wound bed, providing a porous scaffold for cellular infiltration and vascularization before completely degrading via hydrolysis.

Restrata represents a revolution in soft-tissue repair. Proven to provide healing in refractory wounds¹, suitable for patients with ethical or religious objections to skin grafts, and without the special storage and handling requirements of traditional biologics, Restrata is a breakthrough in patient care.

Restrata Sheet

Item #	Size & Configuration	Coverage (cm²)
RWM1-0.5X1	1.3 x 2.5 cm sheet	3.25
RWM1-1X1	2.5 x 2.5 cm sheet	6.25
RWM1-1X2	2.5 x 5 cm sheet	12.5
RWM1-1.5X2	3.8 x 5 cm sheet	19
RWM1-1X3	2.5 x 7.5 cm sheet	18.75
RWM1-2X2	5 x 5 cm sheet	25
RWM1-3X3	7.5 x 7.5 cm sheet	56.25
RWM1-4X5	10 x 12.5 cm sheet	125
RWM1-5X7	12.5 x 17.5 cm sheet	218.75

Restrata Sell Sheet

Restrata Wound Matrix

HCPCS Product Code: A2007 - Restrata, per sq cm

CPT Application Code 15271-15278

Restrata reimbursement support hotline: Call (877) 893-2570 or email support@restratahotline.com

1. Regulski, Matthew J., and Matthew R. MacEwan. "Implantable Nanomedical Scaffold Facilitates Healing of Chronic Lower Extremity Wounds." Wounds: a compendium of clinical research and practice 30.8 (2018): E77-E80. Disclaimer: This has been prepared for providers using Restrata and is intended for informational purposes only. It does not represent a statement promise or guarantee by Acera Surgical, Inc. concerning coverage, levels of reimbursement, payment, or charges. It is not intended to increase or maximize reimbursement. The decision as to how to complete a reimbursement claim form is exclusively the responsibility of. the provider. Reimbursement policies change frequently. The ultimate responsibility for coding and claims submission belongs with the physician, clinician, hospital, or other facility. Restrata is a registered trademark of Acera Surgical, Inc.

Contact an Account Executive

Use Cases

Chronic, Diabetic Foot Ulcers

For clinicians looking for a solution to chronic, diabetic foot ulcers, Restrata has been shown to provide healing in refractory wounds. Many diabetic patients struggle with ulcers that fail to respond to traditional graft treatments for a variety of reasons. Restrata has been shown to provide healing for patients with chronic ulcers that are resistant to other treatments.

Surgical Uses

Many patients face post-surgical wounds that are slow to heal or do not respond to traditional treatment methods. Clinicians searching for an alternative treatment for these patients may find a solution in Restrata. Restrata has been used in conjunction with a variety of surgical procedures, including limb salvage and amputation situations, as well as traumatic crush injuries, burns, and more.

Pressure Ulcers

Improper off-loading, common with patients recovering from knee surgery, may result in pressure ulcers. Restrata has been used to treat and heal these post-surgical complications, including some patients for whom prior treatment options did not help.

Case Studies

Dehisced Surgical Wound Post Amputation

The wound was closed using Restrata with four applications over five weeks.

Dehisced Surgical Wound Post Ankle Fracture

Patient healed in seven weeks with two applications of Restrata.

Dehisced Surgical Wound Post Calcaneal Repair

Patient achieved wound closure after three applications of Restrata.

Diabetic Foot Ulcer

The patient successfully healed after six weeks with three applications.

Pressure Ulcer

Patient healed with two applications of Restrata in three weeks.

Downloads & Whitepapers

Clinical Evaluation of a Novel Nanofiber Wound Matrix

Download

Implantable Nanomedical Scaffold Facilitates Healing

Download

What Makes the Optimal Wound Healing Material?

Download

Frequently Asked Questions

For what uses is Restrata indicated?

Restrata is indicated for several uses, including those listed below.

Partial and full thickness wounds
Pressure sores / ulcers
Venous ulcers
Diabetic ulcers
Tunneled / undermined wounds
Surgical wounds (e.g., donor site / grafts, post-laser surgery, post-Mohs surger, podiatric wounds, dehisced wounds)
Trauma wounds (e.g., abrasions, lacerations, partial thickness burns, skin tears)
Draining wounds

For a full list and additional information, please view our Restrata Indications for Use document.

Has Restrata been used in conjunction with Negative Pressure Wound Therapy?

Restrata has been used in conjunction with Negative Pressure Wound Therapy. For best results, ensure that Restrata is adequately fenestrated and the pressure is reduced.

How do I store Restrata?

Restrata has a two-year shelf life from the packaging date when stored at ambient temperatures. Refer to the expiration date on the product box for details. There are no special storage or handling requirements. Store at room temperature and avoid excessive heat or humidity.

Is there a specific requirement for applying Restrata (i.e. top or bottom)?

No, there is no specific orientation required for application.

Should I remove partially resorbed Restrata?

Pieces of Restrata that are adherent to the wound should be left in place. Pieces that are non-adherent to the wound should be removed and the wound debrided. Re-apply Restrata as needed.

What sizes of Restrata are available?

Restrata is available in several sizes to reduce waste. Currently, the following sizes are available:

12.5cm x 17.5cm (5 x 7in)*
10 x 12.5cm (4 x 5in)*
7.5 x 7.5cm (3 x 3in)*
5.0 x 5.0cm (2 x 2in)*
3.8 x 5.0cm (1.5 x 2in)*
2.5 x 7.5cm (1 x 3in)
2.5 x 5cm (1 x 2in)
2.5 x 2.5cm (1 x 1in)
1.3 x 2.5cm (0.5 x 1in)

* designates that size is also available in a pre-meshed configuration

What types of dressings can be applied over Restrata?

Primary dressing: Non-adherent dressing.
Secondary dressings: For dry to light exudate, adding hydrogel is recommended. For moderate to heavy exudate, fenestrate Restrata to allow for drainage to pass through and utilize appropriate absorptive dressing.
Dressing products can be used safely after application of Restrata.
It is recommended that clinicians manage primary and secondary dressing changes as appropriate.

Other Products

Learn More

Expandable up to 2x the initial coverage area while maintaining strength and integrity to suture or staple. Pre-meshed electrospun fiber matrix contours to the application site requiring soft-tissue repair.

Learn More

Micronized, electrospun fiber matrix engineered to be similar to human ECM. A dispersible form factor of Restrata that may be applied to soft tissue areas with irregular or complex topography.

Learn More

For surgeons who need a dural repair solution, Cerafix is a non-biologic, implantable, bioresorbable, fibrous matrix engineered to offer reliable dural closure, reduce postoperative cerebrospinal fluid leakage (CSF), and support dural restoration.

Learn More

Contact us to learn more!

Get Started

or call (844) 879-2237

Revolutionizing Healing. Changing Lives.

•

Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.

•

Privacy & Security

This website, Acera-Surgical.com, is owned and operated by Acera Surgical. We are strongly committed to protecting the privacy of our website users. The intent of our privacy policy is to inform you, the user, about the information that we may collect about visitors to our site, how we use that information, and about our disclosure practices.

Acera Surgical is committed to high standards that require honesty, integrity and fairness. Acera Surgical will collect no personal information about you unless you choose to provide that information to us. We do not use techniques that collect personal information about you without your knowledge. You have the right to decline to have any information collected or transferred for marketing purposes.

What Happens To Your Personal Information?

All personal information that is collected on our website is stored in a secure location. At no time will Acera Surgical solicit personal information to third party vendors without prior consent, as we respect the privacy and confidentiality of our website visitors.

What About Spam?

Subscribers will not receive any unsolicited emails or correspondence if they have not provided Acera Surgical with prior permission. From time to time, we may use email as a way to keep in touch with our website visitors; however, we do not send “spam” (unsolicited marketing email). If you agree to receive email communications from us, every email message we send to you will include an email address to which you can respond. If at any time you decide you do not want to receive marketing email from us, simply let us know and we will remove your name and email address from our mailing list.

When You Leave This Site

This policy discloses the privacy practices for our website. However, our site contains links to other sites. Once you link to another site, you are subject to the privacy and security policies of the new site. We encourage you to read the privacy policies of all websites you visit, especially if you share any personal information.

Security Policy

Users are prohibited from violating or attempting to violate the security of the site. By way of example, you are prohibited from (a) accessing data not intended for such user or logging onto a server or an account which the user is not authorized to access; (b) attempting to probe, scan or test the vulnerability of a system or network or to breach security without proper authorization; (c) attempting to interfere with service to any user, host or network; (d) sending unsolicited mail, including promotions and/or advertising of products or services.